Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rational selection of oral 5-aminosalicylate formulations and prodrugs for the treatment of ulcerative colitis.

Literature DB >> 12492172

Rational selection of oral 5-aminosalicylate formulations and prodrugs for the treatment of ulcerative colitis.

William J Sandborn.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2002 PMID： 12492172 DOI： 10.1111/j.1572-0241.2002.07092.x

Source DB: PubMed Journal: Am J Gastroenterol ISSN： 0002-9270 Impact factor: 10.864

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

Authors: Yongjun Wang; Claire E Parker; Tania Bhanji; Brian G Feagan; John K MacDonald
Journal: Cochrane Database Syst Rev Date: 2016-04-21

Review 2. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors: Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal: Gut Date: 2019-09-27 Impact factor: 23.059

Rational selection of oral 5-aminosalicylate formulations and prodrugs for the treatment of ulcerative colitis.

Review 1. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

Review 2. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Review 3. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

4. Refractory ulcerative colitis treatment.

Review 5. Treatment of inflammatory bowel disease: a review of medical therapy.

Review 6. Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.

7. Oral Nanoparticles of SNX10-shRNA Plasmids Ameliorate Mouse Colitis.

8. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

9. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

10. Oxidative dehydrogenative couplings of pyrazol-5-amines selectively forming azopyrroles.